Webinar

Clinical Evaluation Under EU MDR (2017/745) 

A CRO Playbook for Building Defensible Clinical Evidence

What this webinar is about:

🟠 Two real-world scenarios:
– Non-CE Class IIb device: pre-market clinical investigation and how CROs operationalize the evidence plan
– CE-marked Class IIb device: post-market evidence generation and maintenance

🟠 How to build a Clinical Evidence Map:
claims → endpoints → acceptance criteria → data sources, ensuring traceability and audit-ready rationale

🟠 Non-CE pathway (pre-market):
CEP → CIP / Protocol linkage, study deliverables (IB, ICF, monitoring, data and safety plans) and common pitfalls that derail approval and later CER conclusions

🟠 CE-marked pathway (post-market):
PMCF / RWE options, CER updates, and how PMS inputs (complaints, trends, vigilance) support defensible clinical conclusions over time

🟠 A CRO playbook for managing information chaos:
standardizing decision documentation, aligning stakeholder expectations, and building evidence packages that stand up to Notified Body and authority scrutiny

If you work in clinical affairs, regulatory strategy or clinical development in MedTech — this session is designed for you
    • 51 minutes

      Course duration
      About the Speaker
      Sabina Nidzworska 
      Quality & Regulatory Expert with 8+ years in the medical-device sector. PhD biotechnologist specializing in ISO 13485 QMS, global compliance and IVDR/MDR registrations (MHRA, TGA). Experienced in managing full-cycle clinical trials—from protocol to final report—for Class II devices, IVDs and dietary supplements in line with ISO 14155 and ICH-GCP.
      Created with